Jin Medical International (ZJYL) Receivables - Net (2022 - 2025)

Jin Medical International (ZJYL) has reported Receivables - Net for 4 consecutive years, with $6.0 million the latest figure, recorded in Q3 2025.

• Quarterly Receivables - Net fell 0.55% year-over-year to $6.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $6.0 million (down 0.55% YoY) and the FY2025 annual result came in at $6.0 million, down 0.55% from the prior year.
• Receivables - Net advanced to $6.0 million in Q3 2025 per ZJYL's latest filing, from $4.3 million in the prior quarter.
• Over the last five years, Receivables - Net for ZJYL reached as high as $6.0 million in Q3 2024 and fell as low as $3.4 million in Q3 2023.
• A 4-year average of $4.5 million and a median of $3.9 million in 2024 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2023 — Receivables - Net fell 11.02% — and 2024, when it soared 75.84%.
• Year by year, Receivables - Net stood at $3.8 million in 2022, then declined by 11.02% to $3.4 million in 2023, then soared by 75.84% to $6.0 million in 2024, then decreased by 0.55% to $6.0 million in 2025.
• According to Business Quant data, Receivables - Net over the past three periods registered $6.0 million, $4.3 million, and $6.0 million for Q3 2025, Q1 2025, and Q3 2024 respectively.